The Lupus Foundation of America joins forces with Lupus Canada to advance lupus innovative research and to fund the research and projects through the Lupus Canada Catalyst Grant. This grant will support high-calibre research projects that will improve drug development and will impact the lives of patients suffering from lupus disease.
The LFA is devoted to solving the mystery of one of the world’s cruellest disease, lupus, the most unpredictable and devastating illness while providing support to the people suffering from the brutal impact of lupus.
Lupus is a long term, systemic autoimmune disease, in which the body’s immune system becomes hyperactive and starts attacking the body’s tissues and organs. There are four different types of lupus; cutaneous, systemic, neonatal and drug-induced lupus.
Its early indicative symptoms are photosensitive rash (particularly appears on the face or upper arms), fever, swelling, pain and stiffness of joints. It can affect different body systems including brain, heart, kidneys and lungs.
According to LFA, approximately 1.5 million people in the United States are suffering from lupus. 90% of diagnosed patients are women. It mostly strikes women of childbearing age. The incidence rate is so much higher than every year16, 000 new cases occur. The Centers for Disease Control and Prevention (CDC) are gathering updated data on the incidence rate of lupus disease in the United States, so the change in this number is expected.
According to an estimate, lupus affects 1:1000 Canadians. It is not contagious and is not linked to cancer or AIDS. It belongs to the category of diseases which includes multiple sclerosis, juvenile diabetes, rheumatoid arthritis and scleroderma. Its most common type is SLE (Systemic lupus erythematosus).
The Ceo and president of LFA, Stevan W. Gibson said it is important to work together for the better treatments and to accelerate the research projects for improving drug development. This collaboration will allow them to join forces to have a better and increased impact of lupus research in North America. It will help them in achieving their common goal of improving the lives of patients suffering from lupus and ending lupus.
Their research program has contributed to each research breakthrough of the previous 40 years. The Lupus Foundation of America is focused and dedicated to uniting the lupus experts around the globe to find the lupus cause, control its symptoms and eventually find a promising cure for lupus.
The volunteer President of Lupus Canada, Tanya Carlton said they are fiercely committed to improving the lives of Canadians suffering from lupus by funding the best lupus researchers in Canada. With the collaboration of Lupus Foundation America, it will be more helpful to advance their mandate and to gather attention globally to the harmful lupus disease.
The Lupus Canada Catalyst Grant is given to Canadian researchers at any level of their lupus research and provides support for preferable startup projects for a year. Applications of Lupus Canada Catalyst Award are currently open until April 17, 2020.
Moreover, the Lupus Foundation of America has also opened its applications for the Gina M. Finzi Memorial Fellowship Grant and the Gary S. Gilkeson Career Development Award. Applications are now open until April 17, 2020.
Life quality can be improved by the comprehensive research programs, advocacy, education and proper awareness. This goal can be achieved through expanded efforts, innovative approach and research initiatives.